Company or ticker...

PTC Therapeutics

PTC develops medicines for rare genetic and neuromuscular diseases.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

PTCT

5.2B

5.9

n/a

-17.92%

Key Facts

M. Cap

PS

PE

YTD

5.2B

5.9

n/a

-17.92%

10MA

20MA

50MA

200MA

$PTCT